For these reasons, "those who promote monopolies should be discouraged and laws should be enacted to prevent barriers of entry not only to products or transportation, but also to professionals," said Flores Bernese, according to Prensalibre.com.
The Mexican official listed the steps required in order to combat anti-competitive monopolistic practices:
"From the perspective of the Federal Commissioner for Competition, the first step after passing the legislation, is to create an independent body that can act legally against offenders. The second step is to direct efforts to reducing the activity of business cartels that set prices jointly. As mentioned, the Federal Competition Commission of Mexico recently received money from fines of $1.83 million to proprietors of a ferry (a type of vessel that joins two points carrying passengers and cars) which provided a service between Isla Mujeres and Carmen beach in Cozumel. Another case involved a group of pharmaceutical companies who paid a fine of $10.7 million for high priced medicines for the Mexican Social Security Institute (IMSS). "
The Law on Promotion of Competition and Effective Consumer Protection recently approved typifies monopolistic practices and changes the rules on economic groups.
Two of the most important changes are expanding the scope of the law, which now includes public service employees in cases of concessions and the introduction of a new absolute monopolistic practice: the agreement between competitors to 'refuse to buy or sell goods or services'.
A law regulating monopolistic behavior received yesterday the initial approval in Congress, despite the dissatisfaction of business groups.
Members of the Committee on Economic Affairs ruled the project called 'Competition Promoting Act', which create the Commission for the Promotion of Competition (COPROCOM) and powers it to confiscate business documents, if authorized by a judge.
Receive more news about Economics
Suscribe FOR FREE to CentralAmericaDATA EXPRESS.
The most important news of Central America, every day.
Construction of a pharmaceutical manufacturing plant. Total cost US$ 2'500'000. We search investors for up to 49%.
Includes building, machinery, start-up expenses, operational capital First year is dedicated to construction. No return. End...